Theriva Biologics (TOVX) Research & Development (2010 - 2026)
Theriva Biologics (TOVX) posted Research & Development of $1.27 million for Q2 2026, down 35.1% from $1.95 million a year earlier but up 257.2% from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Research & Development (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Theriva Biologics was $5.31 million, down 49.7% year-over-year; for FY2025, it came in at $8.6 million, down 28.5% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 10.9% (FY2020 to FY2025).
- In prior years, Theriva Biologics' Research & Development was $12.03 million in FY2024 (-15.9%), $14.31 million in FY2023 (+22.1%), $11.72 million in FY2022 (+50.3%) and $7.8 million in FY2021 (+52.0%).
- Quarterly Research & Development has run from a low of $355,000 in Q1 2026 to a high of $4.2 million in Q4 2023 over five years.
- On a year-over-year basis, Research & Development has declined in each of the last nine quarters, with an average decline of 37.7% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2021, with growth of 183.9%; the weakest was Q1 2026, with a decline of 88.0%.
- According to Business Quant data, Research & Development for the three prior quarters was $355,000 (Q1 2026), $1.13 million (Q4 2025) and $2.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Theriva Biologics | 10.10 Mn | 10.10 Mn | - | 1.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Mar 31, 2026 | 355,000.00 |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 2.89 Mn |
| Sep 30, 2024 | 2.73 Mn |
| Jun 30, 2024 | 2.95 Mn |
| Mar 31, 2024 | 3.46 Mn |
| Dec 31, 2023 | 4.20 Mn |
| Sep 30, 2023 | 4.01 Mn |
| Jun 30, 2023 | 3.13 Mn |
| Mar 31, 2023 | 2.98 Mn |
| Dec 31, 2022 | 3.07 Mn |
| Sep 30, 2022 | 2.57 Mn |
| Jun 30, 2022 | 3.49 Mn |
| Mar 31, 2022 | 2.60 Mn |
| Dec 31, 2021 | 2.78 Mn |
| Sep 30, 2021 | 1.97 Mn |
API Access
Theriva Biologics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();